===== phenotype 21=================================================================
proportion of pts: 0.207060690202
lambda: 7133.10419334
----------------------------------------
Hypertensive disease	0.247
Disorders of lipoid metabolism	0.219
Diseases of esophagus, stomach, and duodenum	0.186
Arthropathies and related disorders	0.184
Symptoms involving respiratory system and other chest symptoms	0.165
----------------------------------------
Anti-Ulcer Agents	0.226
Proton Pump Inhibitors	0.209
Antihypertensive Agents	0.191
Cyclooxygenase Inhibitors	0.188
Anti-Inflammatory Agents, Non-Steroidal	0.185
===== phenotype 40=================================================================
proportion of pts: 0.167393891313
lambda: 7006.56573775
----------------------------------------
Hypertensive disease	0.247
Disorders of lipoid metabolism	0.221
Symptoms involving respiratory system and other chest symptoms	0.191
Acute respiratory infections	0.189
Other diseases of the upper respiratory tract	0.153
----------------------------------------
Antipyretics	0.175
Cyclooxygenase Inhibitors	0.174
Anti-Inflammatory Agents, Non-Steroidal	0.168
Fibrinolytic Agents	0.162
Vasodilator Agents	0.161
Platelet Aggregation Inhibitors	0.160
===== phenotype 12=================================================================
proportion of pts: 0.197937326458
lambda: 6846.12091602
----------------------------------------
Hypertensive disease	0.278
Diabetes	0.270
Disorders of lipoid metabolism	0.261
Symptoms involving respiratory system and other chest symptoms	0.191
----------------------------------------
Antipyretics	0.210
Fibrinolytic Agents	0.203
Platelet Aggregation Inhibitors	0.199
Anticholesteremic Agents	0.198
Anti-Inflammatory Agents, Non-Steroidal	0.191
===== phenotype 22=================================================================
proportion of pts: 0.162633875446
lambda: 6141.46173951
----------------------------------------
Range name na	0.181
Rheumatism, excluding the back	0.174
Hypertensive disease	0.173
Arthropathies and related disorders	0.169
Dorsopathies	0.152
General symptoms	0.151
----------------------------------------
Anti-Anxiety Agents	0.248
Hypnotics and Sedatives	0.200
Anticonvulsants	0.188
Serotonin Uptake Inhibitors	0.184
GABA Modulators	0.181
===== phenotype 43=================================================================
proportion of pts: 0.192383974613
lambda: 6131.61493562
----------------------------------------
Hypertensive disease	0.218
Diabetes	0.208
Disorders of lipoid metabolism	0.195
Disorders of the eye and adnexa	0.192
Range name na	0.187
----------------------------------------
Anti-Arrhythmia Agents	0.235
Diuretics	0.211
Anti-Inflammatory Agents	0.198
Hypoglycemic Agents	0.182
Glucocorticoids	0.174
===== phenotype 36=================================================================
proportion of pts: 0.145973819913
lambda: 5853.67356598
----------------------------------------
Hypertensive disease	0.259
Disorders of lipoid metabolism	0.210
Rheumatism, excluding the back	0.183
Arthropathies and related disorders	0.178
Diabetes	0.169
----------------------------------------
Calcium Channel Blockers	0.228
Analgesics	0.198
Excitatory Amino Acid Antagonists	0.196
Antiparkinson Agents	0.193
Antimanic Agents	0.186
===== phenotype 16=================================================================
proportion of pts: 0.162633875446
lambda: 5465.06985073
----------------------------------------
Hypertensive disease	0.229
Arthropathies and related disorders	0.197
Dorsopathies	0.194
General symptoms	0.193
Rheumatism, excluding the back	0.187
----------------------------------------
Anti-Arrhythmia Agents	0.213
Sympatholytics	0.204
Analgesics, Non-Narcotic	0.202
Diuretics	0.200
Adrenergic beta-1 Receptor Antagonists	0.181
===== phenotype 24=================================================================
proportion of pts: 0.16144387148
lambda: 5059.85424867
----------------------------------------
Rheumatism, excluding the back	0.233
Dorsopathies	0.200
Other symptoms involving abdomen and pelvis	0.194
Diseases of esophagus, stomach, and duodenum	0.188
Arthropathies and related disorders	0.185
----------------------------------------
Anti-Ulcer Agents	0.214
Antipyretics	0.208
Antihypertensive Agents	0.202
Vasodilator Agents	0.193
Proton Pump Inhibitors	0.183
===== phenotype 7=================================================================
proportion of pts: 0.176517255058
lambda: 4994.01444444
----------------------------------------
Hypertensive disease	0.321
Symptoms involving respiratory system and other chest symptoms	0.256
Disorders of lipoid metabolism	0.229
Arthropathies and related disorders	0.194
----------------------------------------
Anti-Inflammatory Agents	0.178
Glucocorticoids	0.177
Bronchodilator Agents	0.172
Tocolytic Agents	0.168
Dermatologic Agents	0.153
Adrenergic beta-2 Receptor Agonists	0.152
===== phenotype 11=================================================================
proportion of pts: 0.158270527568
lambda: 4987.79766408
----------------------------------------
Hypertensive disease	0.315
Range name na	0.251
Disorders of lipoid metabolism	0.233
Arthropathies and related disorders	0.201
----------------------------------------
Immunosuppressive Agents	0.218
Antirheumatic Agents	0.212
Enzyme Inhibitors	0.204
Dermatologic Agents	0.187
Antimetabolites, Antineoplastic	0.179
===== phenotype 0=================================================================
proportion of pts: 0.189210630702
lambda: 4924.56956508
----------------------------------------
Hypertensive disease	0.252
Rheumatism, excluding the back	0.202
Disorders of lipoid metabolism	0.200
Arthropathies and related disorders	0.196
General symptoms	0.151
----------------------------------------
Anti-Allergic Agents	0.284
Histamine H1 Antagonists, Non-Sedating	0.242
Anti-Inflammatory Agents	0.238
Bronchodilator Agents	0.237
===== phenotype 26=================================================================
proportion of pts: 0.149543831813
lambda: 4770.14059046
----------------------------------------
Hypertensive disease	0.219
Other forms of heart disease	0.216
Range name na	0.203
Disorders of lipoid metabolism	0.184
Symptoms involving respiratory system and other chest symptoms	0.178
----------------------------------------
Sodium Potassium Chloride Symporter Inhibitors	0.235
Diuretics	0.224
Adrenergic beta-Antagonists	0.192
Anticoagulants	0.177
Adrenergic alpha-1 Receptor Antagonists	0.171
===== phenotype 45=================================================================
proportion of pts: 0.176913923046
lambda: 4766.63376343
----------------------------------------
Hypertensive disease	0.272
Arthropathies and related disorders	0.256
Range name na	0.238
Disorders of lipoid metabolism	0.233
----------------------------------------
Platelet Aggregation Inhibitors	0.257
Fibrinolytic Agents	0.249
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.249
Antipyretics	0.245
===== phenotype 48=================================================================
proportion of pts: 0.19000396668
lambda: 4657.90123322
----------------------------------------
Hypertensive disease	0.310
Disorders of lipoid metabolism	0.278
Diabetes	0.207
Arthropathies and related disorders	0.204
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.237
Cardiotonic Agents	0.218
Antihypertensive Agents	0.214
Serotonin Uptake Inhibitors	0.169
Antidepressive Agents, Second-Generation	0.163
===== phenotype 19=================================================================
proportion of pts: 0.197937326458
lambda: 4503.81991619
----------------------------------------
Hypertensive disease	0.313
Range name na	0.274
General symptoms	0.214
Arthropathies and related disorders	0.199
----------------------------------------
Vitamins	0.305
Bone Density Conservation Agents	0.279
Cyclooxygenase Inhibitors	0.222
Antioxidants	0.194
===== phenotype 17=================================================================
proportion of pts: 0.149543831813
lambda: 4196.50467759
----------------------------------------
Ischemic heart disease	0.311
Disorders of lipoid metabolism	0.252
General symptoms	0.232
Diseases of male genital organs	0.205
----------------------------------------
Antihypertensive Agents	0.208
Cyclooxygenase Inhibitors	0.204
Antipyretics	0.202
Anti-Inflammatory Agents, Non-Steroidal	0.195
Platelet Aggregation Inhibitors	0.192
===== phenotype 9=================================================================
proportion of pts: 0.160650535502
lambda: 4175.86581917
----------------------------------------
Range name na	0.231
Hypertensive disease	0.214
General symptoms	0.202
Arthropathies and related disorders	0.186
Other forms of heart disease	0.167
----------------------------------------
Antiemetics	0.231
Analgesics	0.203
Histamine H1 Antagonists	0.194
Antipruritics	0.190
Anticonvulsants	0.181
===== phenotype 47=================================================================
proportion of pts: 0.152320507735
lambda: 3996.28720249
----------------------------------------
Range name na	0.281
Hypertensive disease	0.262
Symptoms involving respiratory system and other chest symptoms	0.239
Arthropathies and related disorders	0.217
----------------------------------------
Analgesics, Opioid	0.213
Anti-Inflammatory Agents, Non-Steroidal	0.208
Anti-Arrhythmia Agents	0.205
Cyclooxygenase Inhibitors	0.200
Anesthetics, Local	0.174
===== phenotype 38=================================================================
proportion of pts: 0.166203887346
lambda: 3818.04826868
----------------------------------------
General symptoms	0.253
Other diseases of urinary system	0.213
Disorders of the eye and adnexa	0.194
Other diseases of skin and subcutaneous tissue	0.188
Nephritis, nephrotic syndrome, and nephrosis	0.151
----------------------------------------
Anti-Ulcer Agents	0.237
Proton Pump Inhibitors	0.217
Anti-Inflammatory Agents	0.193
Anti-Allergic Agents	0.190
Bronchodilator Agents	0.163
===== phenotype 28=================================================================
proportion of pts: 0.167790559302
lambda: 3707.46529393
----------------------------------------
Hypertensive disease	0.296
Disorders of lipoid metabolism	0.247
Diabetes	0.242
Range name na	0.215
----------------------------------------
Proton Pump Inhibitors	0.215
Enzyme Inhibitors	0.204
Hypoglycemic Agents	0.203
Vitamin B Complex	0.201
Gout Suppressants	0.177
===== phenotype 44=================================================================
proportion of pts: 0.161840539468
lambda: 3236.96094264
----------------------------------------
Hypertensive disease	0.255
Symptoms involving respiratory system and other chest symptoms	0.219
Diabetes	0.184
Rheumatism, excluding the back	0.173
Range name na	0.170
----------------------------------------
Antiemetics	0.276
Histamine H1 Antagonists	0.253
Antipruritics	0.248
Angiotensin II Type 1 Receptor Blockers	0.223
===== phenotype 32=================================================================
proportion of pts: 0.16501388338
lambda: 3217.91991435
----------------------------------------
Hypertensive disease	0.318
Range name na	0.271
Disorders of lipoid metabolism	0.220
Other forms of heart disease	0.191
----------------------------------------
Anti-Bacterial Agents	0.358
Topoisomerase II Inhibitors	0.233
Anti-Infective Agents, Urinary	0.219
Antimalarials	0.190
===== phenotype 35=================================================================
proportion of pts: 0.170170567235
lambda: 3112.61026642
----------------------------------------
Range name na	0.242
Hypertensive disease	0.233
General symptoms	0.216
Disorders of the eye and adnexa	0.158
Disorders of thyroid gland	0.150
----------------------------------------
Antihypertensive Agents	0.360
Anti-Inflammatory Agents, Non-Steroidal	0.332
Angiotensin-Converting Enzyme Inhibitors	0.308
===== phenotype 13=================================================================
proportion of pts: 0.166600555335
lambda: 3067.81360339
----------------------------------------
Diabetes	0.319
Disorders of lipoid metabolism	0.257
Rheumatism, excluding the back	0.228
Dorsopathies	0.195
----------------------------------------
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.348
Antihypertensive Agents	0.341
Hypoglycemic Agents	0.311
===== phenotype 31=================================================================
proportion of pts: 0.172550575169
lambda: 2791.26469017
----------------------------------------
Range name na	0.289
Symptoms involving respiratory system and other chest symptoms	0.191
Dorsopathies	0.178
Anemias	0.172
Disorders of lipoid metabolism	0.169
----------------------------------------
Anti-Allergic Agents	0.358
Proton Pump Inhibitors	0.325
Bronchodilator Agents	0.317
===== phenotype 25=================================================================
proportion of pts: 0.19357397858
lambda: 2743.546399
----------------------------------------
Hypertensive disease	0.295
Range name na	0.245
Dorsopathies	0.244
Disorders of lipoid metabolism	0.216
----------------------------------------
Anti-Inflammatory Agents	0.340
Antidepressive Agents, Tricyclic	0.339
Anti-Allergic Agents	0.321
===== phenotype 14=================================================================
proportion of pts: 0.134867116224
lambda: 2645.84495883
----------------------------------------
Hypertensive disease	0.268
Range name na	0.203
Disorders of lipoid metabolism	0.194
Symptoms involving respiratory system and other chest symptoms	0.179
Other diseases of intestines and peritoneum	0.156
----------------------------------------
Adjuvants, Anesthesia	0.270
Muscle Relaxants, Central	0.260
Hypnotics and Sedatives	0.241
Anesthetics, Intravenous	0.229
===== phenotype 27=================================================================
proportion of pts: 0.140420468068
lambda: 2612.12826439
----------------------------------------
Other forms of heart disease	0.376
Range name na	0.248
Cerebrovascular disease	0.189
Diseases of arteries, arterioles, and capillaries	0.188
----------------------------------------
Antipyretics	0.285
Antihypertensive Agents	0.281
Cyclooxygenase Inhibitors	0.258
Hypnotics and Sedatives	0.175
===== phenotype 33=================================================================
proportion of pts: 0.151527171757
lambda: 2547.86496001
----------------------------------------
Disorders of lipoid metabolism	0.270
Symptoms involving respiratory system and other chest symptoms	0.260
Hypertensive disease	0.252
Ischemic heart disease	0.218
----------------------------------------
Anti-Anxiety Agents	0.373
Hypnotics and Sedatives	0.338
GABA Modulators	0.289
===== phenotype 15=================================================================
proportion of pts: 0.150733835779
lambda: 2466.82542966
----------------------------------------
Hypertensive disease	0.370
Disorders of lipoid metabolism	0.348
General symptoms	0.282
----------------------------------------
Anticholesteremic Agents	0.360
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.335
Hypolipidemic Agents	0.306
===== phenotype 46=================================================================
proportion of pts: 0.130107100357
lambda: 2463.74975847
----------------------------------------
Symptoms involving skin and other integumentary tissue	0.299
Organic sleep disorders	0.275
Overweight, obesity and other hyperalimentation	0.221
Nonspecific findings on examination of blood	0.205
----------------------------------------
Antihypertensive Agents	0.237
Antipyretics	0.204
Anti-Ulcer Agents	0.194
Anti-Inflammatory Agents, Non-Steroidal	0.188
Proton Pump Inhibitors	0.177
===== phenotype 4=================================================================
proportion of pts: 0.136850456168
lambda: 2339.50502295
----------------------------------------
Diabetes	0.208
Other diseases of the upper respiratory tract	0.208
Acute respiratory infections	0.202
Chronic obstructive pulmonary disease and allied conditions	0.201
Symptoms involving respiratory system and other chest symptoms	0.181
----------------------------------------
Bronchodilator Agents	0.348
Anti-Inflammatory Agents	0.328
Anti-Allergic Agents	0.324
===== phenotype 42=================================================================
proportion of pts: 0.140817136057
lambda: 2302.99056495
----------------------------------------
Hypertensive disease	0.242
Disorders of lipoid metabolism	0.228
General symptoms	0.200
Other diseases of urinary system	0.168
Anemias	0.161
----------------------------------------
Serotonin Uptake Inhibitors	0.417
Antidepressive Agents, Second-Generation	0.378
GABA Modulators	0.206
===== phenotype 10=================================================================
proportion of pts: 0.148353827846
lambda: 2271.75823725
----------------------------------------
Other diseases of urinary system	0.343
Anemias	0.329
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.328
----------------------------------------
Antipyretics	0.256
Anti-Inflammatory Agents, Non-Steroidal	0.255
Cyclooxygenase Inhibitors	0.252
Antihypertensive Agents	0.237
===== phenotype 30=================================================================
proportion of pts: 0.183260610869
lambda: 2147.28884927
----------------------------------------
Disorders of lipoid metabolism	0.310
Hypertensive disease	0.275
Range name na	0.220
Diabetes	0.195
----------------------------------------
Anti-Arrhythmia Agents	0.526
Diuretics	0.474
===== phenotype 39=================================================================
proportion of pts: 0.157477191591
lambda: 2104.66534017
----------------------------------------
Hypertensive disease	0.223
Disorders of lipoid metabolism	0.222
Diabetes	0.210
Range name na	0.195
Anemias	0.151
----------------------------------------
Anti-Ulcer Agents	0.606
Anticonvulsants	0.394
===== phenotype 49=================================================================
proportion of pts: 0.133280444268
lambda: 1767.30267473
----------------------------------------
Range name na	0.330
Other diseases of respiratory system	0.264
Chronic obstructive pulmonary disease and allied conditions	0.240
Certain traumatic complications and unspecified injuries	0.166
----------------------------------------
Antihypertensive Agents	0.345
Antipyretics	0.338
Analgesics, Non-Narcotic	0.316
===== phenotype 6=================================================================
proportion of pts: 0.137643792146
lambda: 1765.95018427
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.334
Diabetes	0.319
Other diseases of respiratory system	0.180
Other symptoms involving abdomen and pelvis	0.168
----------------------------------------
Anti-Bacterial Agents	0.349
Vitamins	0.332
Bone Density Conservation Agents	0.318
===== phenotype 18=================================================================
proportion of pts: 0.156683855613
lambda: 1615.6113214
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.299
Hypertensive disease	0.282
Other diseases of urinary system	0.216
Symptoms involving urinary system	0.203
----------------------------------------
Antihypertensive Agents	0.529
Analgesics, Non-Narcotic	0.471
===== phenotype 29=================================================================
proportion of pts: 0.141213804046
lambda: 1441.1359502
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.226
Other diseases of intestines and peritoneum	0.213
Symptoms involving digestive system	0.199
Other symptoms involving abdomen and pelvis	0.194
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.167
----------------------------------------
Antihypertensive Agents	0.537
Platelet Aggregation Inhibitors	0.463
===== phenotype 5=================================================================
proportion of pts: 0.16144387148
lambda: 1436.19198599
----------------------------------------
Range name na	0.365
Disorders of the eye and adnexa	0.331
Hypertensive disease	0.304
----------------------------------------
Fibrinolytic Agents	0.506
Antihypertensive Agents	0.494
===== phenotype 37=================================================================
proportion of pts: 0.149147163824
lambda: 1418.36762931
----------------------------------------
Acute respiratory infections	0.296
Hypertensive disease	0.290
Other diseases of the upper respiratory tract	0.249
Other symptoms involving abdomen and pelvis	0.166
----------------------------------------
Antihypertensive Agents	0.525
Anti-Allergic Agents	0.475
===== phenotype 34=================================================================
proportion of pts: 0.120587068624
lambda: 1376.60667757
----------------------------------------
Other forms of heart disease	0.308
Hypertensive disease	0.272
Ischemic heart disease	0.253
Disorders of fluid, electrolyte, and acid-base balance	0.167
----------------------------------------
Vasodilator Agents	0.545
Anti-Arrhythmia Agents	0.455
===== phenotype 1=================================================================
proportion of pts: 0.11820706069
lambda: 1193.97758279
----------------------------------------
Other diseases of respiratory system	0.317
Nephritis, nephrotic syndrome, and nephrosis	0.241
Anemias	0.240
Disorders of fluid, electrolyte, and acid-base balance	0.202
----------------------------------------
Fibrinolytic Agents	0.501
Platelet Aggregation Inhibitors	0.499
===== phenotype 3=================================================================
proportion of pts: 0.143990479968
lambda: 948.640697859
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.181
Arthropathies and related disorders	0.174
Mycoses	0.167
Symptoms involving skin and other integumentary tissue	0.163
Diseases of veins and lymphatics, and other diseases of circulatory system	0.161
Infections of skin and subcutaneous tissue	0.155
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 41=================================================================
proportion of pts: 0.180087266958
lambda: 907.378447541
----------------------------------------
Hypertensive disease	0.283
Symptoms involving skin and other integumentary tissue	0.205
Symptoms involving head and neck	0.179
General symptoms	0.167
Na	0.166
----------------------------------------
Anti-Allergic Agents	1.000
===== phenotype 8=================================================================
proportion of pts: 0.120587068624
lambda: 754.17059717
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.291
Hypertensive disease	0.269
Disorders of lipoid metabolism	0.223
Neoplasm of uncertain behavior of other sites & tissues	0.217
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 20=================================================================
proportion of pts: 0.138437128124
lambda: 663.480594542
----------------------------------------
Range name na	0.300
Other inflammatory conditions of skin and subcutaneous tissue	0.289
Disorders of the eye and adnexa	0.218
Disorders of thyroid gland	0.192
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 23=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 2=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
